Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
American Journal of Medical Genetics
|
April 1, 1992
Characterization of a highly polymorphic dinucleotide repeat 150 KB proximal to the fragile X site
G J Riggins, S L Sherman, B A Oostra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2009
Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study
J Tabernero, F Ciardiello, F Rivera, et al.
Anales De Pediatria (Barcelona, Spain : 2003)
|
March 11, 2006
[Clinical guide to the management of patients with Beckwith-Wiedemann syndrome]
P Lapunzina Badía, M del Campo Casanelles, A Delicado Navarro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2013
A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma
A C Roy, S R Park, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 31, 2011
A phase I study of sunitinib in combination with FOLFIRI in patients with untreated metastatic colorectal cancer
N Starling, F Vázquez-Mazón, D Cunningham, et al.
Clinical Genetics
|
May 21, 2013
Could a patient with SMC1A duplication be classified as a human cohesinopathy?
C Baquero-Montoya, M C Gil-Rodríguez, M E Teresa-Rodrigo, et al.
Human Molecular Genetics
|
February 22, 2001
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
W Balemans, M Ebeling, N Patel, et al.
Journal of Inherited Metabolic Disease
|
December 21, 2014
Clinical onset and course, response to treatment and outcome in 24 patients with the cblE or cblG remethylation defect complemented by genetic and in vitro enzyme study data
M Huemer, C Bürer, P Ješina, et al.
Clinical Genetics
|
December 17, 2015
Expanding the clinical spectrum of the 'HDAC8-phenotype' - implications for molecular diagnostics, counseling and risk prediction
I Parenti, C Gervasini, J Pozojevic, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
American Journal of Medical Genetics
|
April 1, 1992
Characterization of a highly polymorphic dinucleotide repeat 150 KB proximal to the fragile X site
G J Riggins, S L Sherman, B A Oostra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2009
Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study
J Tabernero, F Ciardiello, F Rivera, et al.
Anales De Pediatria (Barcelona, Spain : 2003)
|
March 11, 2006
[Clinical guide to the management of patients with Beckwith-Wiedemann syndrome]
P Lapunzina Badía, M del Campo Casanelles, A Delicado Navarro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2013
A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma
A C Roy, S R Park, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 31, 2011
A phase I study of sunitinib in combination with FOLFIRI in patients with untreated metastatic colorectal cancer
N Starling, F Vázquez-Mazón, D Cunningham, et al.
Clinical Genetics
|
May 21, 2013
Could a patient with SMC1A duplication be classified as a human cohesinopathy?
C Baquero-Montoya, M C Gil-Rodríguez, M E Teresa-Rodrigo, et al.
Human Molecular Genetics
|
February 22, 2001
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
W Balemans, M Ebeling, N Patel, et al.
Journal of Inherited Metabolic Disease
|
December 21, 2014
Clinical onset and course, response to treatment and outcome in 24 patients with the cblE or cblG remethylation defect complemented by genetic and in vitro enzyme study data
M Huemer, C Bürer, P Ješina, et al.
Clinical Genetics
|
December 17, 2015
Expanding the clinical spectrum of the 'HDAC8-phenotype' - implications for molecular diagnostics, counseling and risk prediction
I Parenti, C Gervasini, J Pozojevic, et al.
Page
of 4